The web site logo

Login My Account
 Search lipid.org

Summer 2010 Clinical Lipid Update

The Evaluation and Treatment of the Intermediate Risk CHD Patient

August 27-29, 2010 • Mayflower Hotel • Washington, DC

WELCOME

Program Hightlights

Maureen Whelihan, MD

Wm. James Howard, MD, MACP

Southeast Lipid Association President

It is with great pleasure that we invite you to attend the 2010 Summer Clinical Lipid Update. This year´s meeting is jointly hosted by the Southeast and Northeast chapters of the National Lipid Association. Our focus on the intermediate risk patient will present you with the latest lipid science and show you how to apply it to your clinical practice. You will be given the opportunity to earn up to 27 continuing education credits by attending our forum. You can also extend your learning experience by participating in the pre-conference professional development courses offered by the NLA.


Maureen Whelihan, MD

Donald A. Smith, MD, MPH

Northeast Lipid Association President

Thought leaders from the field of lipidology will explore our primary theme, The Evaluation and Treatment of the Intermediate Risk CHD Patient, from a number of different perspectives and will address your current clinical questions over the course of the two-day program. You will gain skills and insight while sharing the best practices with your peers and colleagues from not only the Northeast and Southeast but across the country.



" Outstanding opportunity to interact with thought leaders in a very positive learning environment ".

2009 Scientific
Sessions Attendee






We hope you take advantage of the tremendous educational opportunities offered at this conference, but also make time for relaxation and the cultural offerings in Washington, DC.

Check www.lipid.org/summerclu for up-to-date information and to register. We look forward to seeing you there.



Download Program



  • Risk stratification for targeted CVD prevention
  • Current controversies in lipid management and atherosclerosis prevention
  • Applications and limitations of biomarkers, imaging and advanced lipid testing
  • Management of residual risk
  • How to treat diabetic dyslipidemia
  • Evidence-based diet and lifestyle guidelines
  • Challenging case presentations

2010 Program Chairs

Donald A. Smith, MD,MPH • New York, NY
Thomas N. Tulenko, PhD • Philadelphia, PA
WM. James Howard, MD • Washington, DC
Terry A. Jacobson,MD • Atlanta,GA



Scientific Program
This CME/CE certified activity is
sponsored by the
National Lipid Assosiation
Jointly hosted by the Northeast and
Southeast Regional chapters.
logo, MD